KBC Group NV Buys 22,978 Shares of Cigna Group $CI

KBC Group NV grew its stake in shares of Cigna Group (NYSE:CI) by 6.4% during the second quarter, HoldingsChannel reports. The firm owned 380,034 shares of the health services provider’s stock after purchasing an additional 22,978 shares during the quarter. KBC Group NV’s holdings in Cigna Group were worth $104,768,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Evercore Wealth Management LLC raised its stake in Cigna Group by 2.8% in the first quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider’s stock worth $347,000 after buying an additional 35 shares in the last quarter. Cary Street Partners Investment Advisory LLC boosted its position in Cigna Group by 11.0% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock valued at $100,000 after acquiring an additional 36 shares in the last quarter. OLD National Bancorp IN grew its holdings in shares of Cigna Group by 3.7% during the 4th quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock worth $284,000 after acquiring an additional 37 shares during the period. IHT Wealth Management LLC grew its holdings in shares of Cigna Group by 2.5% during the 4th quarter. IHT Wealth Management LLC now owns 1,535 shares of the health services provider’s stock worth $423,000 after acquiring an additional 38 shares during the period. Finally, Whetstone Capital Advisors LLC raised its position in shares of Cigna Group by 4.9% in the 4th quarter. Whetstone Capital Advisors LLC now owns 829 shares of the health services provider’s stock worth $228,000 after acquiring an additional 39 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Activity at Cigna Group

In related news, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Nicole S. Jones sold 19,436 shares of the business’s stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the transaction, the insider owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by company insiders.

Analyst Ratings Changes

CI has been the topic of several research reports. Piper Sandler dropped their price target on Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a research report on Wednesday, June 3rd. Raymond James Financial lowered Cigna Group from a “strong-buy” rating to an “outperform” rating and lowered their price objective for the company from $350.00 to $320.00 in a research report on Monday, August 3rd. UBS Group boosted their target price on shares of Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a report on Friday, May 22nd. Barclays upped their target price on shares of Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Finally, Wolfe Research reissued an “outperform” rating and set a $315.00 price target on shares of Cigna Group in a research report on Tuesday, June 16th. Fifteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $339.45.

Cigna Group Price Performance

Shares of NYSE:CI opened at $282.24 on Friday. The business has a fifty day moving average price of $286.02 and a 200-day moving average price of $281.28. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The company has a market capitalization of $74.58 billion, a PE ratio of 11.68, a PEG ratio of 0.97 and a beta of 0.29. Cigna Group has a 1-year low of $239.51 and a 1-year high of $315.47.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating the consensus estimate of $7.60 by $0.18. The company had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. Cigna Group’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period in the prior year, the firm posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities analysts expect that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio is presently 25.82%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.